Neuroleptic medications have been implicated in a wide variety of movement disorders. Early adverse reactions include acute dystonia, Parkinsonism and akathisia. Complications occurring after prolonged neuroleptic exposure, (usually years, but occasionally after a few months' 2) are termed "tardive" movement disorders. The most common and most frequently recognised are the oral, lingual, buccal movements termed tardive dyskinesias. The prevalence of these movements in the neuroleptic treated population varies from 0-5% to 51b6%, depending on the study with an average of 20%.3 Less frequently described is tardive dystonia.
Tardive dystonia is defined as a chronic dystonia, occurring for the first time after a minimum of 2 months of neuroleptic use in a patient without another explanation (such as stroke, Huntington's disease, Parkinson's disease, Wilson's disease) who has a negative family history for the disorder.1 It is frequently present with the more common, oralbuccal-lingual movements of tardive dyskinesia."4 Although many studies have been performed analysing prevalence rates and risk factors for tardive dyskinesia3 no published study has focused on the prevalence and risk factors for dystonia. Owens et al' in a survey of a psychiatric hospital found a prevalence of 2-2% of retrocollis or torticollis and 2-7% of truncal torsion movements in a psychiatric hospital but gave no further description. No other dystonias were noted and the possibility of some of these cases being acute dystonic reactions must be considered.
We report the findings of our survey of patients of a total of 331 patients, housed in September, 1984, in the Institute for Mental Health (IMH), the only public supported psychiatric hospital in Rhode Island. This is the first report of the prevalence of tardive dystonia in any population.
Subjects
The patients housed in the IMH, are similar to those in most public psychiatric hospitals. Patients suffering from Alzheimer's disease, moderate to severe retardation or who are outside the age range of 18-70 years are hospitalised elsewhere. The policy regarding patients with other organic neurological disorders which include behaviour disorders is less clear, so that some patients have had strokes, subarachnoid haemorrhages, hypoglycaemic encephalopathy or head trauma. These patients, with organic disorders represent however a small minority of the population. All have behavioural abnormalities. Aside from this mixture of "organic" and "non-organic" cases, there is also a mixture of acutely, chronically, and intermittently hospitalised patients. These patients are unable, for psychiatric or social reasons, to be maintained outside the hospital. The acutely hospitalised patients generally lack health insurance. By and large, these patients are poorly educated and come from low income families. Friedman, Kucharski, Wagner of tardive dystonia of 1-5%. The results from our method of withholding the first daily dose of medication is obviously confounded by the variable pharmacodynamics of the different drugs used. Patients on long acting depot medications clearly were not influenced by this tactic. Other patients, whose doses may have been given unevenly during the day, clearly were subject to different stresses and pharmacological changes. While some of these unavoidable deficits were corrected by repeated evaluations at random times during the normal workday without alterations in drug regimen, patients initially missed on the first screening were not re-evaluated. Therefore this estimate is clearly an under-reporting.
Another problem with this study is that none of these patients has had a complete battery of tests including CT scan, serum ceruloplasmin and slit lamp exam of the eyes. Although Wilson's disease may develop late in life,9 it is unlikely (although not impossible) without a family history for this or other diseases to have been overlooked. Because this study was specifically designed to find dystonia, milder cases might have been picked up than would "ordinarily" be the case in a tardive dyskinesia screening. Only one case whose dystonia resolved would fall into this category.
Follow up one year after initial evaluation revealed significant changes in the movements of three patients. One had marked resolution of torticollis but newly developed blepharospasm and akathisia. One had marked worsening of blepharospasm and akathisia. The one female improved. The prevalence of dystonia varies with ethnic origin. In the US population as a whole, the frequency is estimated at 0-3 per 100,00016 making our prevalence of 1-5% unexpectedly high.
We conclude, from our study and the several reports in the literature that tardive dystonia, secondary to neuroleptic medications exists, that it has a Tardive dystonia in a psychiatric hospital prevalence in a chronic care psychiatric population of 1-2%, and that mental retardation and ECT appear to be risk factors for its development.
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